Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 81

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 81
---
2024June 30, 2025June 30, 2024Amortization of debt issuance costs and debt discount, included in interest expense$0.6 $2.1 $1.1 $4.0 Interest expense$1.9 $1.4 $3.7 $3.1 

9.        Accrued Expenses

Accrued expenses consisted of the following:(in thousands)June 30, 2025December 31, 2024Registration penalties$1,583 $1,583 Board of directors fees172 249 Employee compensation906 2,232 Other628 614 Accrued expenses$3,289 $4,678 

10.        Fair Value Measurements

The Company uses various inputs to measure the outstanding warrants on a recurring basis to determine the fair value of the liabilities. The following tables classify the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy:Fair value measured at June 30, 2025(in thousands)Fair value atJune 30, 2025Quoted prices inactive markets(Level 1)Significant otherobservable inputs(Level 2)Significantunobservable inputs(Level 3)Warrant liability$12,018 $- $- $12,018 Fair value measured at December 31, 2024(in thousands) Fair value at December 31, 2024Quoted prices inactive markets(Level 1)Significant otherobservable inputs(Level 2)Significant unobservable inputs(Level 3)Warrant liability$8,107 $- $- $8,107 There were no transfers among Levels 1, 2 or 3 during the three and six months ended June 30, 2025, and 2024. Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with liabilities within the Level 3 category include changes in fair value that were attributable to both observable and unobservable inputs.Warrant LiabilityThe Company's liability classified warrants as of June 30, 2025, and December 31, 2024, were valued using the Black Scholes valuation model.

16

Significant Black Scholes valuation model inputs related to the Company’s warrants are listed below:June 30, 2025December 31, 2024